Arlington Capital Management’s Novo Nordisk NVO Stock Holding History

Arlington Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$276K	Buy
2024 Q2	–	Sell
2024 Q1	$1.22M	Buy
2023 Q4	$985K	Buy